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jP-14.017jPharmacological fMRI comparing escitalopram
and citalopram
R. Lanzenberger1, C. Windischberger1, C. Spindelegger1, P. Stein1,
U. Moser1, S. Kasper1. 1Medical University of Vienna, Austria
Objective : Pharmacological functional magnetic resonance imaging
(phfMRI) is a promising new tool to measure the eﬀects of study
drugs on task-speciﬁc neural activation with high spatial and suf-
ﬁcient temporal resolution. Here we investigated diﬀerences in brain
activation by short-term administration of two frequently prescribed
selective serotonin reuptake inhibitors.
Methods : 18 healthy subjects underwent 3 fMRI sessions in a ran-
domized, placebo-controlled, double-blind, cross-over repeated mea-
sures design. Escitalopram (10 mg/d), citalopram (20 mg/d) and
placebo were administered for 10 days each after a period of at least 3
weeks free of drugs. During fMRI, the subjects performed an
emotional discrimination task of facial expression and a sensorimotor
control task. Main drug eﬀect was calculated in SPM using a whole-
brain ANOVA. Post-hoc paired t-tests were performed to reveal sig-
niﬁcant diﬀerences between escitalopram and placebo, citalopram
and placebo, and escitalopram and citalopram.
Results : Signiﬁcant eﬀects of escitalopram and citalopram adminis-
tration on task-speciﬁc neural reactivity in the steady state were
found in the medial frontal gyrus, amygdala, parahippocampus,
fusiform cortex, middle temporal gyrus, but not in primary and
secondary visual cortices strongly activated by this task (ANOVA).
Both escitalopram and citalopram compared to placebo decreased
the activation in the right amygdala and left parahippocampus
(t-tests). We found signiﬁcant diﬀerences between escitalopram
and citalopram in the parahippocampal and fusiform cortices
(escitalopram>citalopram) and in the medial frontal gyrus (escitalo-
pram<citalopram).
Conclusion : Drug eﬀects were area-speciﬁc focused on brain
regions known for dense serotonergic projections. Both escitalopram
and citalopram attenuated the reactivity of the right amygdala and
left parahippocampus to emotional versus neutral stimuli indic-
ating speciﬁc eﬀects on emotional processing. The signiﬁcant more
pronounced inhibitory modulation of the medial frontal gyrus in
the escitalopram condition might be a biological explanation for re-
sponse diﬀerences between both study drugs demonstrated in clinical
trials.
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jP-14.019jThe timing of prenatal immune challenge
determines the extent of postnatal white matter
microstructural anomalies in a mouse model
of schizophrenia
Q. Li1, C. Cheung1, V. Cheung2, X. Zhang1, R. Wei1, P. Wong1, Y. You3,
E. Hui1, S. Chua1, G. McAlonan1, E.X. Wu1. 1The University of Hong
Kong, Hong Kong SAR, China ; 2The HK Polytechnic University, Hong
Kong SAR, China ; 3HKUST, Hong Kong SAR, China
Objective : Neurodevelopmental disorders like schizophrenia have
onset early in fetal life and epidemiological studies implicate prenatal
maternal inﬂammation as a risk factor. Human studies indicate white
matter connections are disrupted, but direct evidence for a fetal
trigger of brain structural changes is sparse. In this study we tested the
hypothesis that maternal immune activation causes post-natal white
matter microstructural anomalies in oﬀspring relevant to schizo-
phrenia. We have previously shown that early pregnancy immune
challenge triggers more extensive anatomical and behavioural abnor-
malities than later exposure. Therefore we examined the eﬀects of
maternal inﬂammation in early and late gestation on white matter
microstructure in the oﬀspring using advanced in-vivo diﬀusion
tensor imaging (DTI).
Methods : We used automated voxel-based morphometry (VBM)
of in-vivo DTI data to map fractional anisotropy (FA, directional
diﬀusion of water) in white matter of adult oﬀspring exposed to either
viral mimic PolyI :C or saline (control) on early (day 9) or late (day 17)
gestation. In addition we conducted a preliminary immunohisto-
chemical exploration using the oligodendrocyte marker CNPase to
determine whether myelination processes might contribute to any
changes in FA observed.
Results : FA was lower in MIA exposed oﬀspring throughout fron-
to-striatal-limbic circuits and in the corpus callosum. Regions with
lower FA were more extensive in the early exposed group. In both
groups there were regions with increased FA but again, these were
more extensive in the early exposed group. Preliminary im-
munohistochemical evidence revealed reduction in the oligoden-
drocyte marker CNPase in mice exposed to MIA, consistent with a
white matter structural insult aﬀecting myelination.
Conclusion : The present results provide direct experimental
evidence that prenatal inﬂammation causes white matter microstruc-
tural abnormalities analogous to those found in schizophrenia.
Maternal inﬂammation earlier in gestation precipitates more exten-
sive changes in oﬀspring, suggesting that the fetus is more vulnerable
to environmental insults associated with schizophrenia early in de-
velopment.
Policy of full disclosure : None.
jP-14.020jAcute basal ganglia infarcts in poststroke fatigue :
An MRI study
J. Lu1, K.C. chen1, V. Mok1, W.C. Chu1, G.S. Ungvari1, A.T. Ahuja1,
K.S. Wong1, W.K. Tang1. 1CUHK, Hongkong, Hong Kong SAR, China
Objective : A total of 334 Chinese patients with acute ischemic
stroke consecutively admitted to the acute stroke unit of a
university-aﬃliated regional hospital in Hong Kong participated in
the study.
Methods : At admission, a host of demographic and clinical
characteristics was collected and the number and location of acute
infarcts were evaluated with MRI. All participants were assessed
for PSF with the Fatigue Severity Scale (FSS) 3 months after their
index stroke. PSF was deﬁned as a mean FSS score of 4.0 or more.
Depressive symptoms were measured by the Geriatric Depression
Scale (GDS).
Results : Seventy-eight (23.4%) patients had PSF. In the univariate
analysis, the PSF group included more females, had higher GDS
scores, and a higher number of acute infarcts, and the PSF patients
were more likely to have acute infarcts at the BG. Acute BG infarct
remained an independent predictor of PSF in the multivariate
analysis.
Conclusion : In conclusion, these results suggest that BG infarcts
may play a role in the development of PSF.
Policy of full disclosure : jinyan lu.
jP-14.021jSerotonin-1A receptor binding in the hypothalamus
predicts the plasma level of dehydroepiandrosterone
sulfate in healthy women
U. Moser1, W. Wadsak1, P. Stein1, C. Spindelegger1, M. Mitterhauser1,
L.-K. Mien1, K. Kletter1, S. Kasper1, R. Lanzenberger1. 1Medical
University of Vienna, Austria
Objective : Serotonin modulates the activity of the hypothalamic-
pituitary-adrenal (HPA) axis to a big part through the serotonin-1A
receptor (5-HT1A). Disturbances in the HPA-axis, as well as changes
of the 5-HT1A receptor binding potential (BP) in distinct brain regions
are strongly associated to depression and anxiety disorders.
Therefore, the rationale of this positron emission tomography (PET)
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